Clinical Trials (HCV)
Phase II VX-497 Clinical Trials of VX-497 for Hepatitis C Begin
Published in Medical Letter on the CDC and FDA, October 5th, 1998
With the trial announced, Vertex is expanding the scope of the VX-497 development program to explore the potential antiviral activity of the compound, in addition to developing it as a drug for autoimmune indications. Vertex next plans to initiate a Phase II clinical trial in psoriasis, an autoimmune disease of the skin.
VX-497 is a potent inhibitor of inosine monophosphate dehydrogenase (IMPDH), a human enzyme that is essential for production of nucleotides - the building...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Conference Coverage (ICAAC)
Work Remains on Lyme Disease Vaccine - Disease Associations
Flu Shots Can Be a Life Preserver for People With Diabetes, CDC Says - Epidemiology
M. malmoense Infection Still Rare in U.S. - Epidemiology (ICAAC Conference News)
CDC Study: Two-Thirds of U.S. Infected With Herpes - Nosocomial Infection
Common Infection Causing Uncommon Problems in Hospitals - Outbreaks (TB)
Clinton County Revisited: More Must be Done in Poor, Rural Areas - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
